EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases report

Jun Kong, Ze Tian, Dao-Xing Deng, Xiao-Dong Mo

Annals of Hematology · 29.09.2025 · 104 (10) · 5537-5541

DOI: 10.1007/s00277-025-06591-9 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 29.09.2025. Verfasst von Jun Kong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Ke…. Hauptthemen laut MEDLINE: Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation, Adamantane. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Key Research and Development Program of China, the Natural Science Foundation of Beijing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transplantation-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of hematopoietic stem cell transplantation (HSCT). With mortality rates up to 90% without timely treatment, effective management remains a challenge. Complement dysregulation plays a central role in TA-TMA pathogenesis. We reported two TA-TMA cases successfully treated with iptacopan, a factor B inhibitor targeting the alternative pathway. A 40-year-old male with early T-cell precursor acute lymphoblastic leukemia developed early-onset TA-TMA post-HSCT, and a 41-year-old female with acute myeloid leukemia arising from previous myelodysplastic syndrome developed delayed-onset TA-TMA after allo-HSCT. Iptacopan administration led to significant clinical and biochemical recovery in both two patients. These two cases highlight iptacopan's potential as an effective therapy for TA-TMA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thrombotic MicroangiopathiesHematopoietic Stem Cell TransplantationAdamantaneHumansAdultMaleFemaleLeukemia, Myeloid, AcutePrecursor T-Cell Lymphoblastic Leukemia-LymphomaBenzoatesIndolesPiperidines

Stichwörter der Autor:innen

Hematopoietic stem cell transplantationIptacopanThrombotic microangiopathy

Substanzen

AdamantaneiptacopanBenzoatesIndolesPiperidines

Autor:innen und Institutionen

  • Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Pe…
  • Peking University People's Hospital, Peking University Institute of Hematology, No. 11 Xizhimen South Street, Xicheng District, Beijing, 100044, China. mxd453@163.com.

Förderung

  • the National Key Research and Development Program of China
  • the Natural Science Foundation of Beijing

Zitieren

APA

Kong, J., Tian, Z., Deng, D. X., & Mo, X. D. (2025). Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases report. Annals of Hematology, 104(10), 5537-5541. https://doi.org/10.1007/s00277-025-06591-9

Vancouver

Kong J, Tian Z, Deng DX, Mo XD. Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases report. Annals of Hematology. 2025;104(10):5537-5541. doi:10.1007/s00277-025-06591-9

BibTeX
@article{Kong2025,
  author = {Kong, Jun and Tian, Ze and Deng, Dao-Xing and Mo, Xiao-Dong},
  title = {Treatment of transplantation-associated thrombotic microangiopathy with iptacopan: two cases report},
  journal = {Annals of Hematology},
  year = {2025},
  volume = {104},
  number = {10},
  pages = {5537--5541},
  doi = {10.1007/s00277-025-06591-9}
}
Kostenlos starten →